Prurigo

Dermatology·MeSH: Prurigo

5 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
incb054707	Incyte Corp. (INCY)

Phase 2(2)

Drug	Company
rocatinlimab	AMGEN INC (AMGN)
zumilokibart	Apogee Therapeutics, Inc. (APGE)

Phase 2/Phase 3(2)

Drug	Company
haduvio	Trevi Therapeutics, Inc. (TRVI)
nalbuphine er	Trevi Therapeutics, Inc. (TRVI)

BioSniper tracks 5 drugs in development for Prurigo across 4 companies.

There are 1 clinical trial targeting Prurigo tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.